$21.7m NHMRC funding for UoN
Friday, 25 October 2013
$21.7m funding puts University of Newcastle in Top Eight universities for health and medical research.
The University of Newcastle has been awarded $21.7 million by the National Health and Medical Research Council (NHMRC), placing it seventh in Australia for University-based health and medical research funding in the 2013 funding round.
The NHMRC funding for UON will support 31 research projects including nine research fellowships.
"The funding of $21.7 million is the highest total NHMRC funding ever awarded to Newcastle, and we have secured our highest ever share of the national funds available this year," Vice-Chancellor, Professor Caroline McMillen, said.
"UON also achieved the highest overall application success rate of any university in the country."
Acting Deputy Vice-Chancellor (Research), Professor Nick Talley, said UON's outstanding results were a tribute to the commitment, innovation and consistent focus on delivering world-class research by Newcastle's researchers and their support teams.
"Newcastle is home to health and medical researchers who are global leaders in their field. These funding results speak to the enormous talent and energy that position the University of Newcastle and the Hunter as a centre of excellence for research that delivers terrific health and medical outcomes for our community."
The NHMRC funding includes:
- $2.2million for a collaborative project between the University's Professor John Forbes and Associate Professor Prudence Francis, to test a new treatment for breast cancer that involves combining chemotherapy with oestrogen-lowering treatment before surgery with the aim of shrinking the cancer to improve surgery options.
- $2 million in three grants to Laureate Professor Paul Foster and his team to understand the causes, and reduce the impact, of respiratory infections and inflammatory airways diseases, allergies and severe and childhood asthma.
- $1.8million to Professor John Attia and his team to set up a novel multi-centre trial to investigate the effects of pneumococcal vaccination in reducing heart attacks and stroke.
- $1.7million to Dr Vanessa Murphy and her team to test whether an asthma management strategy, which determines treatment changes based on a marker of airway inflammation, improves outcomes for maternal, neonatal and child health.
- $1.5million to Professor Rob-Sanson-Fisher to assess factors that affect outcomes for people seeking treatment for alcohol dependence.
- $1.2million to Professor Phil Hansbro to explore whether using modified gut microbes assists in controlling lung inflammation in people with emphysema, a condition for which there are currently no treatments.
Health researchers are members of the Hunter Medical Research Institute (HMRI), a partnership between Hunter New England Health, the University of Newcastle and the community.
|Contact||Carmen Swadling, Media and Public Relations.|
|Phone||+61 2 4985 4276|